![Jeffrey Rosenfeld](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Rosenfeld
Voorzitter bij
CLINUVEL PHARMACEUTICALS LIMITED
Vermogen: 20 679 $ op 31-05-2026
Profiel
Jeffrey Rosenfeld is currently the Chairman at Clinuvel Pharmaceuticals Ltd. He previously worked as the Director-Neurosurgery at Alfred Health and as the Head-Surgery & Professor at Monash University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-06-2025 | 3.148 ( 0,01% ) | 20 679 $ | 31-05-2026 |
Actieve functies van Jeffrey Rosenfeld
| Bedrijven | Functie | Begin |
|---|---|---|
| CLINUVEL PHARMACEUTICALS LIMITED | Voorzitter | 01-01-2024 |
Eerdere bekende functies van Jeffrey Rosenfeld
| Bedrijven | Functie | Einde |
|---|---|---|
Monash University
 Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Alfred Health
 Alfred Health Hospital/Nursing ManagementHealth Services Operates as a hospital | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
7
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Clinuvel Pharmaceuticals Ltd.
 Clinuvel Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for patients with genetic, metabolic and life-threatening disorders | Health Technology |
Monash University
Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alfred Health
Alfred Health Hospital/Nursing ManagementHealth Services Operates as a hospital | Health Services |
